Form 4: Lemaitre Vascular Executive Trent G. Kamke Reports Stock Transactions

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations.

Summary

• Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular, reported transactions involving the company's common stock on December 2, 2024.
• He acquired 2 shares of common stock through the release of dividend equivalent rights.
• He also disposed of 46 shares to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Mr. Kamke directly owns 4,517 shares of Lemaitre Vascular common stock.
• He also holds 11.3733 dividend equivalent rights.

Sentiment

Score: 5

Explanation: The document reflects routine transactions related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to executive compensation and does not indicate any significant change in the company's operations or outlook. It is common for executives to receive stock-based compensation and to have shares withheld to cover tax obligations.

Comparison to Industry Standards

• Stock-based compensation is a common practice across the industry, particularly for publicly traded companies like Lemaitre Vascular.
• The vesting of restricted stock units and the subsequent tax withholding are standard procedures.
• The price of $105.47 per share is consistent with the market price of the stock at the time of the transaction.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to executive compensation and do not represent a significant change in the company's ownership structure.

Key Dates

Keywords

Lemaitre Vascular, insider trading, stock transaction, Form 4, dividend equivalent rights, restricted stock units, tax withholding, executive compensation